臨床婦人科産科73巻5号

2019年05月発行

今月の臨床 妊婦の腫瘍性疾患の管理―見つけたらどう対応するか

悪性疾患

妊婦の卵巣がんの管理

著者： 秋山梓¹

所属機関： ¹筑波大学医学医療系産科婦人科学

ページ範囲：P.480 - P.486

文献概要

●妊娠中に診断される悪性腫瘍のうち卵巣がんの頻度は比較的高く，早期で診断される症例が多い．

●胎児の器官形成期である第1三半期での化学療法は推奨されないが，必要時には第2・第3三半期以降で化学療法を行うことは可能であり，TC療法を行うのが比較的安全である．

●妊娠中の卵巣がんに対するエビデンスに基づいた標準治療はない．母体の生命を第一に考え，胎児への影響や家族の意思も勘案して症例ごとに治療を検討していくことが必要である．

参考文献

1）Hoover K, et al : Evaluation and management of adnexal mass in pregnancy. Am J Obstet Gynecol 205 : 97-102, 2011

2）Oehler MK, et al : Gynaecological malignancies in pregnancy : a review. Aust N Z J Obstet Gynaecol 43 : 414-420, 2003

3）Whitecar MP, et al : Adnexal masses in pregnancy : a review of 130 cases undergoing surgical management. Am J Obstet Gynecol 181 : 19-24, 1999

4）Kobayashi Y, et al : A Japanese survey of malignant disease in pregnancy. Int J Clin Oncol, 2018［Epub ahead of print］

5）Fruscio R, et al : Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol 41 : 108-117, 2017

6）Timmerman D, et al : Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery : prospective validation by IOTA group. BMJ 341 : c6839, 2010

7）de Haan L, et al : Difficulties with diagnosis of malignancies in pregnancy. Best Pract Res Clin Obstet Gynaecol 33 : 19-32, 2016

8）Han SN, et al : Physiologic variations of serum tumor markers in gynecological malignancies during pregnancy. BMC 10 : 86, 2012

9）宮地　徹，他（編） : 産婦人科病理学診断図譜第3版．pp242-243，杏林書院，1998

10）Glanc P, et al : Adnexal masses in pregnant patient : a diagnostic and management challenge. Ultrasound 24 : 225-240, 2008

11）日本婦人科腫瘍学会 : 卵巣がん治療ガイドライン2015年版．金原出版，2015

12）Amant F, et al : Gynaecologic cancer complicating pregnancy : an overview. Best Pract Res Clin Obstet Gynaecol 24 : 61-79, 2010

13）Morice P, et al : Gynaecological cancers in pregnancy. Lancet 379 : 558-569, 2012

14）Reedy MB, et al : Laparoscopy during pregnancy : a surgery of laparoscopic surgeons. J Reprod Med 42 : 33-38, 1997

15）Amant F, et al : Gynecologic cancers in pregnancy : guidelines of a second international consensus meeting. Int J Gynecol Cancer Off J Int Gynecol Cancer 24 : 394-403, 2014

16）Fruscio R, et al : Ovarian cancer in pregnancy. Best Pract Res Clin Obstet Gynaecol 41 : 108-117, 2017

17）Mancari R, et al : Treatment options for pregnant women with ovarian tumors. Int J Gynecol Cancer 24 : 967-972, 2014

18）Van Calsteren K, et al : Pharmacokinetics of chemotherapeutic agents in pregnancy. Acta Obstet Gynecol Scand 89 : 1338-1345, 2010

19）Mancari R, et al : Treatment options for pregnant women with ovarian tumors. Int J Gynecol Cancer 24 : 967-972, 2014

20）Han SN, et al : Management of gynecological cancers during pregnancy. Curr Oncol Rep 16 : 415, 2014

21）Kim WY, et al : A woman with a balanced autosomal translocation who received chemotherapy while pregnant. Med Health 79 : 396-399, 1996

22）Peccatori FA, et al : Cancer, pregnancy and fertility : ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24 : 160-170, 2013

23）Hassan MS, et al : Teratogenic effect of cisplatin in rats and the protective role of sodium selenite. Toxicol Pathol 68 : 277-287, 2016

24）National Toxicology Program : NTP Monograph : Developmental effects and pregnancy outcomes associated with cancer chemotherapy use during pregnancy. NTP Monogr 2 : i-214, 2013

25）de Haan J, et al : Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy : a 20-year international cohort study of 1170 patients. Lancet Oncol 19 : 337-346, 2018

26）Cardonick E, et al : Maternal and fetal outcmes of taxane chemotherapy in breast and ovarian cancer during pregnancy : case series and review of the literature. Ann Oncol 23 : 3016-3023, 2012

27）Dilek I, et al : Hematological malignancy and pregnancy : a single-institution experience of 21 cases. Clin Lab Haematol 28 : 170-176, 2006

28）Elit L, et al : An endodermal sinus tumor diagnosed in pregnancy. Gynecol Oncol 72 : 123-127, 1999

29）Ezoe S : Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J Environ Res Public Health 9 : 2444-2453, 2012

30）Stensheim H, et al : Cause-specific survival for women diagnosed with cancer during pregnancy or lactation. J Clin Oncol 27 : 45-51, 2009